Lack of functional erythropoietin receptors of cancer cell lines
Erythropoietin (Epo) therapy reduces red cell transfusion requirements and improves the quality of life of anemic cancer patients receiving chemotherapy. However, there is concern that Epo may promote tumor growth. We investigated by real-time RT-PCR, immunofluorescence microscopy, Western blotting...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2007
|
| 在線閱讀: | https://doi.org/10.1002/ijc.23201 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.23201 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|